Lung cancer screening with low dose CT requires careful consideration

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Results from the American National Lung Screening Trial (NLST) show a significant reduction in lung cancer and all-cause mortality in a high risk population screened with annual low-dose CT. Handling of pulmonary nodules, false positive tests, overdiagnosis, psychosocial consequences and cost-efficiency etc. are all aspects that require careful consideration. This paper gives an overview of the current knowledge on these issues. Before a recommendation can be made, we need an overall evaluation of both the benefits and harms in CT screening for lung cancer.

TidsskriftUgeskrift for Laeger
Udgave nummer42
StatusUdgivet - 13 okt. 2014

ID: 221821709